Search your symptoms with MEDgle. You can check your symptoms. It is a medical symptom search allowing you find out what options make sense for you.
CLOSE
PATIENT GPS
patients
healthcare providers
how it works
about
login
edit search
new search
symptoms
diagnoses
physicians
drugs
procedures
close
symptoms
diagnoses
drugs
procedures
physicians
symptom duration
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
gender
male
female
age
1-3
4-11
12-17
18-29
30-50
50+
age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
calculate
visual
[hide visual search]
search visually
symptoms
|
diagnoses
|
drugs
|
procedures
|
physicians
search symptoms
•
Find causes for your symptoms
•
Discover relevant types of physicians
search diagnoses
•
Understand the details of a diagnosis
•
Learn about relevant tests and treatments
•
Find useful resources on the web
search drugs
•
Learn about different therapeutic drugs
•
Understand what they are used for
•
Know the potential options
search procedures
•
Learn about different diagnostic and therapeutic procedures
•
Understand what they are used for
•
Know the potential options
search physicians
•
Find physicians in your area
•
Understand what they do
•
Get the right help you need
matinib
reduced results from
147 billion
82 million
2 million
23680
to ~230 options
options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications
what is 'matinib'?
Definition for matinib
matinib is medication used for such diagnoses as: metastases, malignancy.
diagnoses treated with 'matinib'
1 - 2 of
2
diagnosis
metastases
spread of malignant tumors to other body sites
web search for:
matinib and metastases
malignancy
cancer
web search for:
matinib and malignancy
related procedures when taking 'matinib'
1 - 5 of
148
procedures
Abdominal CAT Scan
web search for:
matinib and Abdominal CAT Scan
Abdominal MRI
MRI of abdominal contents
web search for:
matinib and Abdominal MRI
Array genomic hybridization
web search for:
matinib and Array genomic hybridization
BUN
web search for:
matinib and BUN
Bacille Calmette-Guérin (BCG)
web search for:
matinib and Bacille Calmette-Guérin (BCG)
Beta-2 microglobulin
web search for:
matinib and Beta-2 microglobulin
Biopsy
web search for:
matinib and Biopsy
Biopsy skin
web search for:
matinib and Biopsy skin
Bladder tumor antigen (BTA)
web search for:
matinib and Bladder tumor antigen (BTA)
Brachytherapy
Sealed source radiotherapy
web search for:
matinib and Brachytherapy
Brain MRI
web search for:
matinib and Brain MRI
Breast Self Exams
web search for:
matinib and Breast Self Exams
Brush Cytology
web search for:
matinib and Brush Cytology
CA 125 (cancer antigen 125)
web search for:
matinib and CA 125 (cancer antigen 125)
CA 15-3 (cancer antigen 15.3)
web search for:
matinib and CA 15-3 (cancer antigen 15.3)
CA 19-9 (cancer antigen 19-9)
web search for:
matinib and CA 19-9 (cancer antigen 19-9)
CA 27.29 ((cancer antigen 27.29)
web search for:
matinib and CA 27.29 ((cancer antigen 27.29)
CA 72-4 (cancer antigen 72-4)
web search for:
matinib and CA 72-4 (cancer antigen 72-4)
CT Guided Needle Biopsy
web search for:
matinib and CT Guided Needle Biopsy
CT Pelvis
web search for:
matinib and CT Pelvis
for more please login, login is free (click to login)
related medication for 'matinib'
1 - 5 of
80
drugs
5-fluorouracil (5-fu)
web search for:
matinib and 5-fluorouracil (5-fu)
6-mercaptopurine (6-mp)
web search for:
matinib and 6-mercaptopurine (6-mp)
actinomycin-d
web search for:
matinib and actinomycin-d
alemtuzumab
web search for:
matinib and alemtuzumab
alkylating agents
web search for:
matinib and alkylating agents
altretamine
web search for:
matinib and altretamine
anastrozole
web search for:
matinib and anastrozole
anti tumor antibiotics
web search for:
matinib and anti tumor antibiotics
antimetabolites
web search for:
matinib and antimetabolites
arsenic trioxide
web search for:
matinib and arsenic trioxide
bevacizumab
web search for:
matinib and bevacizumab
bexarotene
web search for:
matinib and bexarotene
bicalutamide
web search for:
matinib and bicalutamide
bleomycin
web search for:
matinib and bleomycin
bortezomib
web search for:
matinib and bortezomib
busulfan
web search for:
matinib and busulfan
capecitabine
web search for:
matinib and capecitabine
carmustine (bcnu)
web search for:
matinib and carmustine (bcnu)
cetuximab
web search for:
matinib and cetuximab
chlorambucil
web search for:
matinib and chlorambucil
for more please login, login is free (click to login)
The following are types of physicians relevant for 'matinib'.
related types of physicians 'family practitioner, internist, oncologist'
show local physicians
postal code
Find Local
stars represent relevance to topic not rating
more
The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested.
web search results for 'matinib'?
Results
1 - 50
- matinib
Imatinib - Wikipedia, the free encyclopedia
Imatinib is a drug used to treat certain types of cancer. It is currently marketed by ... Imatinib may also have a role in the treatment of pulmonary ...
http://en.wikipedia.org/wiki/Imatinib
en.wikipedia.org
-
summary
Imatinib: MedlinePlus Drug Information
Imatinib is used to treat certain types of leukemia (cancer that begins in the white ... Imatinib is also used to treat gastrointestinal stromal tumors (GIST; ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a606018.html
www.nlm.nih.gov
-
summary
imatinib (oral) medical facts from Drugs.com
Physician reviewed imatinib (oral) patient information - includes imatinib description, dosage and directions.
http://www.drugs.com/mtm/imatinib.html
www.drugs.com
-
summary
Gleevec (Imatinib Mesylate) Drug Information: Uses, Side ...
Learn about the prescription medication Gleevec (Imatinib Mesylate), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
http://www.rxlist.com/gleevec-drug.htm
www.rxlist.com
-
summary
imatinib-oral Glossary of Terms with Definitions on ...
imatinib-oral glossary includes a list of imatinib-oral related medical definitions and related links on MedicineNet.com
http://www.medicinenet.com/imatinib-oral/glossary.htm
www.medicinenet.com
-
summary
Imatinib mesylate - Yahoo! Health
Imatinib is available as capsules you can swallow. ... Treatment with imatinib is expected to continue for life to keep the cancer from coming back.2 A study ...
http://health.yahoo.com/other-other/imatinib-mesylate/healthwise--tv7950.html
health.yahoo.com
-
summary
Imatinib mesylate: in the treatment of gastrointestinal ...
Imatinib mesylate: in the treatment of gastrointestinal stromal tumours. ... Imatinib mesylate (imatinib) is an orally administered competitive inhibitor of the tyrosine kinases ...
http://www.ncbi.nlm.nih.gov/pubmed/12600228
www.ncbi.nlm.nih.gov
-
summary
Imatinib: Drug Information Provided by Lexi-Comp: Merck ...
Imatinib may be confused with dasatinib, erlotinib, nilotinib, sorafenib, sunitinib ... Imatinib and its active metabolite are found in human breast milk; the milk ...
http://www.merck.com/mmpe/lexicomp/imatinib.html
www.merck.com
-
summary
Imatinib mesylate
Imatinib is an effective medicine for the treatment of CML.1 ... Imatinib should be used only under the supervision of a medical oncologist or ...
http://www.webmd.com/cancer/imatinib-mesylate
www.webmd.com
-
summary
Imatinib (Oral Route): Before using - MayoClinic.com
Mayo Clinic offers award-winning medical and health information and tools for healthy living. ... Infection?Imatinib may decrease your body's ability to fight infection. ...
http://www.mayoclinic.com/health/drug-information/DR601855/DSECTION=before-using
www.mayoclinic.com
-
summary
imatinib - PubChem Public Chemical Database
Imatinib is a small molecule kinase inhibitor.Gleevec film-coated tablets contain imatinib mesylate equivalent to 100mg or 400 mg of imatinib free base. ...
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=123596
pubchem.ncbi.nlm.nih.gov
-
summary
Gastro-intestinal stromal tumours (GIST) - imatinib
Imatinib is recommended at a dose of 400 mg a day as the first choice ... Imatinib is recommended at a dose of 400 mg a day as the first choice of treatment for ...
http://www.nice.org.uk/page.aspx?o=226184
www.nice.org.uk
-
summary
Imatinib Tablets Facts and Comparisons at Drugs.com
All about Imatinib Tablets. View complete and up to date Imatinib information - part of the Drugs.com trusted medication database.
http://www.drugs.com/cdi/imatinib.html
www.drugs.com
-
summary
IMATINIB - ORAL (Gleevec) side effects, medical uses, and ...
Read more about the prescription drug IMATINIB - ORAL. ... USES: Imatinib is used to treat a type of leukemia (chronic myeloid leukemia or CML) as well as certain ...
http://www.medicinenet.com/imatinib-oral/article.htm
www.medicinenet.com
-
summary
Imatinib (oral) - Yahoo! Health
What is the most important information I should know about imatinib? Do not use this medication without telling your doctor if you are pregnant. ...
http://health.yahoo.com/cancer-medications/imatinib-oral/hea...
health.yahoo.com
-
summary
Dasatinib or high-dose imatinib for chronic-phase chronic ...
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial. ...
http://www.ncbi.nlm.nih.gov/pubmed/17317857
www.ncbi.nlm.nih.gov
-
summary
Imatinib (Oral Route) - MayoClinic.com
Imatinib is a new type of medication that prevents and stops the growth of cancer cells. ... Imatinib helps your body stop making these abnormal white blood cells. ...
http://www.mayoclinic.com/health/drug-information/DR601855
www.mayoclinic.com
-
summary
Imatinib: MedlinePlus medicinas
El imatinib se usa para tratar ciertos tipos de leucemia (cáncer que empieza en los glóbulos blancos) y otros cánceres de las células sanguíneas. ...
http://www.nlm.nih.gov/medlineplus/spanish/druginfo/meds/a606018-es.html
www.nlm.nih.gov
-
summary
Imatinib Mesylate Drug Information, Professional
Imatinib Mesylate Drug Information from Drugs.com. Includes Imatinib Mesylate side effects, interactions and indications.
http://www.drugs.com/mmx/imatinib-mesylate.html
www.drugs.com
-
summary
Leukaemia (chronic myeloid) - imatinib
NICE has recommended that imatinib should be the first treatment considered for an adult with the Philadelphia-chromosome type of CML in the chronic phase. ...
http://www.nice.org.uk/guidance/TA70
www.nice.org.uk
-
summary
Specific targeted therapy of chronic myelogenous leukemia ...
Specific targeted therapy of chronic myelogenous leukemia with imatinib. ... Imatinib, an ATP-competitive selective inhibitor of Bcr-Abl, has unprecedented efficacy ...
http://www.ncbi.nlm.nih.gov/pubmed/12869662
www.ncbi.nlm.nih.gov
-
summary
IMATINIB - ORAL (Gleevec) side effects, medical uses, and ...
Read doctor-produced health and medical information written for you to make informed decisions about your health concerns. ... View All 5 imatinib-oral Health News " ...
http://www.medicinenet.com/imatinib-oral/index.htm
www.medicinenet.com
-
summary
Leukemia-Treatment Overview
The goal of treatment for leukemia is to destroy the leukemia cells and allow normal Learn more. ... Imatinib (Gleevec) may be combined with other drugs to treat the disease. ...
http://www.webmd.com/cancer/tc/leukemia-treatment-overview?page=2
www.webmd.com
-
summary
Gastrointestinal stromal tumours - sunitinib
Sunitinib is recommended as a possible treatment for people with unresectable or ... tumours if they have already tried imatinib treatment but it has not worked or ...
http://guidance.nice.org.uk/TA179
guidance.nice.org.uk
-
summary
Therapy options in imatinib failures.
Despite this advance, not all patients benefit from imatinib because of resistance and intolerance. ... Nilotinib, an analogue of imatinib, also has demonstrated activity in ...
http://www.ncbi.nlm.nih.gov/pubmed/18448557
www.ncbi.nlm.nih.gov
-
summary
Gleevec - NextBio Literature
Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the ... Imatinib mesylate is a small molecule that inhibits activation of the KIT and ...
http://www.nextbio.com/b/search/lit/Gleevec?type=compound&preSelectedTags=author
www.nextbio.com
-
summary
TA70 Leukaemia (chronic myeloid) - imatinib: Guidance
Imatinib is recommended as an option for the treatment of. people with Philadelphia ... Imatinib (Glivec) is the first in a new class of cancer drugs, ...
http://www.nice.org.uk/nicemedia/pdf/TA70_Imatinib_fullguidance.pdf
www.nice.org.uk
-
summary
The tyrosine kinase inhibitor imatinib fails to inhibit ...
Imatinib targets KIT and platelet-derived growth factor receptors (PDGFR) and is highly effective in the treatment of CML and GIST patients. ...
http://www.ncbi.nlm.nih.gov/pubmed/15893416
www.ncbi.nlm.nih.gov
-
summary
Imatinib resistance in gastrointestinal stromal tumors.
The reported mechanism of imatinib resistance in GISTs involves missense mutation in the kinase domain of KIT, including Thr670Ile, Tyr823Asp, and Val654Ala. ...
http://www.ncbi.nlm.nih.gov/pubmed/15946589
www.ncbi.nlm.nih.gov
-
summary
Gastro-intestinal stromal tumours (unresectable/metastatic ...
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Institute's response to consultee and commentator comments on the draft scope ...
http://www.nice.org.uk/guidance/index.jsp?action=download&o=45262
www.nice.org.uk
-
summary
Synthesis and positron emission tomography studies of carbon ...
Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec) ... Here we labeled imatinib with carbon-11 as a tool for determining the drug ...
http://www.ncbi.nlm.nih.gov/pubmed/17307123
www.ncbi.nlm.nih.gov
-
summary
PHENYTOIN SUSPENSION - ORAL (Dilantin) side effects, medical ...
Consumer information about the medication PHENYTOIN SUSPENSION - ORAL (Dilantin), includes side effects, drug interactions, recommended dosages, and storage ...
http://www.medicinenet.com/phenytoin_suspension-oral/page2.htm
www.medicinenet.com
-
summary
Sutent Official FDA information, side effects and uses.
Accurate, FDA approved Sutent information for healthcare professionals and patients - brought to you by Drugs.com.
http://www.drugs.com/pro/sutent.html
www.drugs.com
-
summary
Warfarin Oral : Uses, Side Effects, Interactions, Pictures ...
Find patient medical information for Warfarin Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
http://www.webmd.com/drugs/drug-3949-Warfarin+Oral.aspx?drug...
www.webmd.com
-
summary
Neoplasia: Enhanced phosphorylation of Nbs1, a member of DNA ...
ABL kinase inhibitor imatinib mesylate (IM) was obtained from Novartis Pharma AG ... Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1924483
www.pubmedcentral.nih.gov
-
summary
Dasatinib in imatinib-resistant Philadelphia chromosome ...
BACKGROUND: The BCR-ABL tyrosine kinase inhibitor imatinib is effective in Philadelphia chromosome-positive (Ph-positive) leukemias, but relapse ...
http://www.ncbi.nlm.nih.gov/pubmed/16775234
www.ncbi.nlm.nih.gov
-
summary
Leukaemia (chronic myeloid) - imatinib
Leukaemia (chronic myeloid) - imatinib. Guidance chapters. Table of ... This extract does not constitute the full guidance on this subject and may be ...
http://guidance.nice.org.uk/TA70/Guidance?egpType=selection
guidance.nice.org.uk
-
summary
Control of aggressive fibromatosis by treatment with imatinib ...
OBJECTIVE: There has been only one report available that focuses on the treatment with imatinib mesylate of two individual persons with aggressive fibromatosis. ...
http://www.ncbi.nlm.nih.gov/pubmed/17453242
www.ncbi.nlm.nih.gov
-
summary
Imatinib in small cell lung cancer.
Imatinib was delivered at 600 mg on a daily basis. Response was evaluated at 6 weeks using SWOG criteria. RESULTS: As planned in the study design, ...
http://www.ncbi.nlm.nih.gov/pubmed/12867062
www.ncbi.nlm.nih.gov
-
summary
Imatinib use either pre- or post-allogeneic hematopoietic ...
Imatinib use either pre- or post-allogeneic hematopoietic cell ... Since the introduction of imatinib mesylate, the role of allogeneic hematopoietic cell transplantation (allo ...
http://www.ncbi.nlm.nih.gov/pubmed/19204709
www.ncbi.nlm.nih.gov
-
summary
Imatinib mesylate causes hypopigmentation in the skin.
BACKGROUND: Imatinib mesylate is a tyrosine kinase inhibitor that targets the BCR-ABL protein in CML, c-kit (KIT) and platelet-derived growth factor receptors. ...
http://www.ncbi.nlm.nih.gov/pubmed/14635084
www.ncbi.nlm.nih.gov
-
summary
Fatigue Relief Complex Oral : Uses, Side Effects ...
Find patient medical information for Fatigue Relief Complex Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
http://www.webmd.com/drugs/drug-64160-Fatigue+Relief+Complex...
www.webmd.com
-
summary
Phase I and pharmacokinetic study of imatinib mesylate in ...
Plasma and urine were assayed for concentrations of imatinib and its active metabolite, CGP74588. ... Renal excretion of imatinib was less than 10% of the total dose in ...
http://www.ncbi.nlm.nih.gov/pubmed/18235115
www.ncbi.nlm.nih.gov
-
summary
Sunitinib Malate (Oral Route) - MayoClinic.com
Mayo Clinic offers award-winning medical and health information and tools for healthy living. ... stop the cancer from growing or when the patient cannot take imatinib mesylate. ...
http://www.mayoclinic.com/health/drug-information/DR602399
www.mayoclinic.com
-
summary
[Combination of imatinib and anagrelide in treatment of ...
The prognosis of patients treated with imatinib in BP is worse than in CP. ... No study about the use of imatinib with anagrelide in BP has been found. ...
http://www.ncbi.nlm.nih.gov/pubmed/17091608
www.ncbi.nlm.nih.gov
-
summary
Imatinib compared with interferon and low-dose cytarabine for ...
Imatinib compared with interferon and low-dose cytarabine for newly ... We compared the efficacy of imatinib with that of interferon alfa combined with low-dose ...
http://www.ncbi.nlm.nih.gov/pubmed/12637609
www.ncbi.nlm.nih.gov
-
summary
Imatinib - Wikipedia, la enciclopedia libre
El imatinib es un medicamento usado para tratar ciertos tipos de cáncer. ... El imatinib puede tener utilidad también en el tratamiento de la hipertensión pulmonar. ...
http://es.wikipedia.org/wiki/Imatinib
es.wikipedia.org
-
summary
Hematologic and cytogenetic responses to imatinib mesylate in ...
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. ... Imatinib mesylate, formerly STI571, is a selective inhibitor of this kinase. ...
http://www.ncbi.nlm.nih.gov/pubmed/11870241
www.ncbi.nlm.nih.gov
-
summary
Imatinib mesylate reduces endoplasmic reticulum stress and ...
Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice. ... We studied the effect of imatinib on diabetes in db/db mice and ...
http://www.ncbi.nlm.nih.gov/pubmed/19171749
www.ncbi.nlm.nih.gov
-
summary
Imatinib-intolerant chronic myeloid leukaemia - dasatinib and ...
Imatinib-intolerant chronic myeloid leukaemia - dasatinib and nilotinib: appraisal consultation document ... Imatinib-intolerant chronic myeloid leukaemia - dasatinib and ...
http://www.nice.org.uk/guidance/index.jsp?action=folder&o=47296
www.nice.org.uk
-
summary
show more
1
2
Chat with eNurse Kim about 'matinib' or something else!
quick facts
related diagnosis category
oncology
faq/about
|
disclaimer
|
privacy policy
|
terms of service
|
browse
|
beta
|
contact
|
API - Catalyst
MEDgle does not provide medical advice, diagnosis or treatment. Copyright 2006-2012, MEDgle Inc. All Rights Reserved. MEDgle is NOT affiliated with Google. Last Updated: Mar 14, 2012
This site complies to the
HONcode standard for trustworthy health
information:
verify here
.
Invited Sponsor for Communications Conference
Finalist -- search & reference
MEDgle has been selected for the 2009 Best of Business Award in the Medical research